Literature DB >> 9690701

Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine.

L L von Moltke1, D J Greenblatt, D A Ciraulo, J M Grassi, B W Granda, S X Duan, J S Harmatz, R I Shader.   

Abstract

The activity of D-fenfluramine, L-fenfluramine, and phentermine as inhibitors of five human cytochromes P450 was evaluated using human liver microsomes in vitro. All three compounds produced negligible inhibition of P450-1A2, -2C9, -2E1, and -3A. Phentermine also did not inhibit P450-2D6. However, D- and L-fenfluramine significantly inhibited P450-2D6 activity as measured by dextromethorphan O-demethylation, with mean 50% inhibitory concentrations (15.1 microM) within one order of magnitude of that for fluoxetine (2.7 microM). Findings from the in vitro assay are consistent with clinical studies showing significant inhibition of desipramine clearance by coadministration of fenfluramine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690701     DOI: 10.1097/00004714-199808000-00015

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  5 in total

Review 1.  In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions.

Authors:  Parthena Martin; Maciej Czerwiński; Pallavi B Limaye; Brian W Ogilvie; Steven Smith; Brooks Boyd
Journal:  Pharmacol Res Perspect       Date:  2022-06

Review 2.  In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions.

Authors:  Parthena Martin; Maciej Czerwiński; Pallavi B Limaye; Seema Muranjan; Brian W Ogilvie; Steven Smith; Brooks Boyd
Journal:  Pharmacol Res Perspect       Date:  2022-06

Review 3.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

4.  Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat.

Authors:  Andrew J Grottick; Kevin Whelan; Erin K Sanabria; Dominic P Behan; Michael Morgan; Carleton Sage
Journal:  Psychopharmacology (Berl)       Date:  2014-12-20       Impact factor: 4.530

5.  5-alpha-dihydrotestosterone elevations associated with phentermine use.

Authors:  Scott M Pearson; Jennifer M Trujillo; Michael T McDermott
Journal:  Ther Adv Endocrinol Metab       Date:  2018-05-20       Impact factor: 3.565

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.